Sean Polete, right, his sons Jacob, center, and Alexander, left, at a Dragon’s game together in 2017. Jacob died by suicide in 2018
Oakwood father questions the role of antidepressants in his son’s suicide death
An Oakwood father whose teen son died by #suicide wants parents to research and ask questions about antidepressants prescribed to their children.
Those drugs come with a warning: “May cause increased thoughts of #suicide in children, teens and young adults.”
The so-called “black box” warning is the most serious the Food and Drug Administration can assign to a drug. But it has caused controversy.
Some parents believe they’ve been under-informed about the risks. Doctors, though, fear over-emphasis of the warning scares off patients whose lives could be saved and improved by these drugs.
The Dayton Daily News’ Path Forward project digs into the most pressing issues facing the Miami Valley, including rising concerns about youth mental health. Teen #suicide rates in Ohio are at the highest they’ve been since at least 2000.
Sean Polete is one local parent who shared his concerns about antidepressants and whether a prescription contributed to the #suicide death of his 16-year-old son, Jacob Polete, on Nov. 30, 2018.
“(The doctor) didn’t mention anything about a black label. He didn’t mention this was an off-label use,” he said. The drug he received wasn’t approved to treat #depression in teens, but that doesn’t mean doctors can’t prescribe it.
“I didn’t do the research because I felt like, well, I’m just happy to have somebody giving us some advice,” the Oakwood father said. It wasn’t until after his son died that he started reading about the warnings attached to antidepressants.
“These antidepressants and things have significantly different effects on a child’s brain and it’s much different than the adult brain,” Sean Polete said.
For most children, the drugs work, said Dr. Grace Matheson, a child psychiatrist at Dayton Children’s Hospital.
“We don’t want them to be afraid of the medicine,” she said.
#JamesDonaldson notes:
Welcome to the “next chapter” of my life… being a voice and an advocate for #mentalhealthawarenessandsuicideprevention, especially pertaining to our younger generation of students and student-athletes.
Getting men to speak up and reach out for help and assistance is one of my passions. Us men need to not suffer in silence or drown our sorrows in alcohol, hang out at bars and strip joints, or get involved with drug use.
Having gone through a recent bout of #depression and #suicidalthoughts myself, I realize now, that I can make a huge difference in the lives of so many by sharing my story, and by sharing various resources I come across as I work in this space. #http://bit.ly/JamesMentalHealthArticle
Black box warning
In 2004 the FDA added the warning, which appears in a black box on the information packet with each prescription of antidepressant medications.
It stems from several studies of clinical trials in the United Kingdom and United States in which it was found that about 4% of patients younger than 18 experienced increased suicidal thoughts while on #antidepressant drugs compared to 2% on placebos.
None of the patients in the clinical trials that were reviewed died by #suicide.
In 2006 the FDA expanded the warning to include 36 #antidepressants and raised the age of the warning to 24 years old.
Since those trials were done and the warning was added, doctors and researchers have seen some evidence that the warning might scare off patients who would benefit from taking #antidepressant drugs.
“An increasing number of reports have questioned the actual validity of the FDA warning, especially considering a decline in the prescription of #antidepressant drugs associated with an increase in the rate of suicidal events among people with severe #depression,” a 2019 study in Frontiers in Psychiatry says.
In other words, some data indicates prescriptions for #antidepressants in young people declined after the warning was added, while youth #suicides have been on the rise. But other studies point out that the rate of prescription has come back up in recent years.
“The vast majority of cases, the medication will really help the child feel better,” Matheson said. “And if they are having #suicidal thoughts as part of their #depression, it will relieve those in most cases. But there are those kids who have the adverse effects.”
The majority of research agrees that the warning is warranted, and parents simply need to be better educated about the true risks and benefits of these medications.
“There are people who, because they’ve heard about increased #suicides, they’ve heard these medicines don’t work, (they’ve been) scared off,” said T.J. Grimm, retail and ambulatory director for University Hospitals in Cleveland, and president elect of the Ohio Pharmacists Association. “Their first call isn’t to their physician or pharmacist but to WebMD.”
A goal of the warning was to strengthen safeguards for children by encouraging close monitoring while they are on antidepressants. But a 2008 study in the American Journal of Psychiatry found the frequency of doctor visits by juvenile patients with new prescriptions for antidepressants didn’t increase after the warning was issued. There is no evidence that the warning has increased communication between patients, their parents and their doctors overall.
Nationwide Children’s Hospital in Columbus hosts the #CenterforSuicideResearchandPrevention. Researchers there confirmed the FDA’s findings of overall increased risk of suicidal thoughts and attempts in young people on antidepressants but found that the benefits outweigh the risks.
Future research should focus on how to best monitor children taking antidepressants, that study says, which could increase the confidence of parents and doctors in using the drugs.
‘We were not prepared’
Jacob Polete wasn’t new to behavioral health medication. He’d taken attention deficit hyperactivity disorder medications when he was younger and complained of having dark thoughts, his father said.
As he got older, the Oakwood high school student developed a love of music, science and the outdoors. He conducted sometimes questionable chemistry experiments, like taking caffeine he’d distilled himself. He was an intelligent and inquisitive kid whose grades didn’t reflect his smarts, according to his dad.
Jacob had been seeing a therapist to talk through issues, including his parents’ divorce. But he didn’t disclose that he was having suicidal thoughts until he was hospitalized following the caffeine incident.
His parents met with his doctor before he was given an antidepressant. Sean Polete, a Navy veteran who said he has struggled with #depression himself, asked some questions about whether that was the right medication for his son.
But the black box warning was never brought up, Sean Polete said, neither was the fact that the drug prescribed is not FDA-approved for patients younger than 25 and therefore was “off-label.”
“This was an adult medication,” Sean Polete said.
He later learned that the first six weeks on a new psychiatric medication are the riskiest.
“We were not prepared for that,” he said.
When Jacob came home on the medication, his father said he seemed to do better and even wanted to return to school quickly. Three weeks later, he killed himself.
Sean Polete said he’s not sure how much the medication contributed to his son’s death, but he wished the family had had more information.
“He was more troubled than we knew, or the medication sent him for a loop and exacerbated his symptoms,” he said.
Doctors say it’s important for parents to ask questions about the medications prescribed to their children.
“The important thing is that people are aware that this can happen,” Matheson said. “I usually tell people if you see that your kid is feeling worse instead of better, make sure you’re calling the doctor.”
Sometimes a child prescribed antidepressants actually has a form of bipolar disorder that wasn’t detected, she said. In those cases, the medication can make them manic, which increases the risk of #suicide.
“The parents need to be watching out for any of these changes,” Matheson said. “Since we don’t see the child every day, the parent is going to be the eyes and ears.”
Pharmacists can be a resource to ask questions as well.
“People need to ask their pharmacists to tell them about the medicine every time they get a new prescription,” Grimm said.
The existence of a warning on antidepressants does not obligate a pharmacist to discuss the potential risks with a patient. Pharmacy groups have debated whether that discussion should be mandatory, but no policy changes have been settled on.
Sean Polete recommends that parents develop trust with their child’s doctor and get as much information as possible, so they feel comfortable with the action plan.
“Have the doctors help you craft a plan,” Sean Polete said, including how the family will be involved in monitoring and supporting the patient, especially during the first six weeks on a new medication.
He also wishes doctors would only choose off-label uses of medication as a last resort.
Matheson said many antidepressants are not approved by the FDA for use by children but are very commonly prescribed off-label or for a different use than indicated by the FDA. She starts children on lower doses and builds up.
“In general the reason why one would be approved and not another just has to do with whether somebody has done the randomized controlled trial,” she said. Doing trials on children is tricky, so many medications haven’t gone through that process, even though they’ve been seen to work and written up in literature.
“Most of them work in a very similar way, so we can sort of extrapolate from the adult data,” Matheson said. “It doesn’t mean that it’s not safe or it doesn’t work.”
James Donaldson is a Washington State University graduate (’79). After an outstanding basketball career with WSU, he went on to play professional basketball in the NBA with the Seattle Supersonics, San Diego/L.A. Clippers, Dallas Mavericks, New York Knicks, and Utah Jazz. He also played for several teams in the European Leagues in Spain, Italy, and Greece, and he toured with The Harlem Globetrotters to wrap up his career. James was an NBA All-Star in 1988 while playing center for the Dallas Mavericks. In 2006, James was inducted into the Pac-10 Sports Hall of Fame and also the Washington State University Athletic Hall of Fame. In 2010, James was elected as a board member for the NBA Retired Players Association.
James frequently conducts speaking engagements (motivational, inspirational, educational) for organizations, schools, and youth groups.
In 2010, James was the recipient of the NBA Legends of Basketball ABC Award, awarded for outstanding contributions in Athletics–Business–Community.
He believes in being a role model for success and professionalism to the scores of young people to whom he devotes so much of his time. He currently serves on several boards and committees and is a member of many organizations.
James believes in developing relationships that create a “Win-Win” environment for everyone involved, and in being the best he can be!
For more information about James Donaldson or to request he speak at your event, contact him at:
www.StandingAboveTheCrowd.com
[email protected]
1-800-745-3161 (voicemail & fax)
James Donaldson is the author of “Standing Above The Crowd” and “Celebrating Your Gift of Life” and founder of the Your Gift of Life Foundation which focuses on mental health awareness and suicide prevention, especially pertaining to our school aged children and men.
If you’re interested in having James come and speak to your group of young adults, business entrepreneurs, aspiring political and community leaders, and athletic teams, please contact him at [email protected] and or leave a personal message for him at 1-800-745-3161. Keep up with him and read about how he is reaching out and making a difference in the lives of so many around the world at www.yourgiftoflife.org
